Risë B Goldstein1,2, Sharon M Smith3,4, S Patricia Chou3, Tulshi D Saha3, Jeesun Jung3, Haitao Zhang3, Roger P Pickering3, W June Ruan3, Boji Huang3, Bridget F Grant3. 1. Laboratory of Epidemiology and Biometry, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Ln., M.S. 9304, Bethesda, MD, 20892, USA. goldster@mail.nih.gov. 2. Health Behavior Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd., Room 7B13C, Bethesda, MD, 20892, USA. goldster@mail.nih.gov. 3. Laboratory of Epidemiology and Biometry, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Ln., M.S. 9304, Bethesda, MD, 20892, USA. 4. Translational Blood Science and Resources Branch, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Dr., Bethesda, MD, 20892, USA.
Abstract
OBJECTIVES: To present current, nationally representative US findings on the past-year and lifetime prevalences, sociodemographic correlates, psychiatric comorbidity, associated disability, and treatment of DSM-5 posttraumatic stress disorder (PTSD). METHODS: Face-to-face interviews with 36,309 adults in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III. PTSD, alcohol and drug use disorders, and selected mood, anxiety, and personality disorders were assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5. RESULTS: Past-year and lifetime prevalences were 4.7 and 6.1 %, higher for female, white, Native American, younger, and previously married respondents, those with <high school education and lower incomes, and rural residents. PTSD was significantly associated with a broad range of substance use, mood, anxiety, and personality disorders, and past-month disability. Among respondents with lifetime PTSD, 59.4 % sought treatment; an average of 4.5 years elapsed from disorder onset to first treatment. CONCLUSIONS: DSM-5 PTSD is prevalent, highly comorbid, disabling, and associated with delayed help seeking. Additional research is needed to elucidate relationships identified herein, estimate PTSD-related costs, investigate hypotheses regarding etiology, course, and treatment, and support decisions about resource allocation to service delivery and research. Initiatives are needed to destigmatize PTSD, educate the public about its treatment, and encourage affected individuals to seek help.
OBJECTIVES: To present current, nationally representative US findings on the past-year and lifetime prevalences, sociodemographic correlates, psychiatric comorbidity, associated disability, and treatment of DSM-5 posttraumatic stress disorder (PTSD). METHODS: Face-to-face interviews with 36,309 adults in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions-III. PTSD, alcohol and drug use disorders, and selected mood, anxiety, and personality disorders were assessed using the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5. RESULTS: Past-year and lifetime prevalences were 4.7 and 6.1 %, higher for female, white, Native American, younger, and previously married respondents, those with <high school education and lower incomes, and rural residents. PTSD was significantly associated with a broad range of substance use, mood, anxiety, and personality disorders, and past-month disability. Among respondents with lifetime PTSD, 59.4 % sought treatment; an average of 4.5 years elapsed from disorder onset to first treatment. CONCLUSIONS: DSM-5 PTSD is prevalent, highly comorbid, disabling, and associated with delayed help seeking. Additional research is needed to elucidate relationships identified herein, estimate PTSD-related costs, investigate hypotheses regarding etiology, course, and treatment, and support decisions about resource allocation to service delivery and research. Initiatives are needed to destigmatize PTSD, educate the public about its treatment, and encourage affected individuals to seek help.
Authors: Maxia Dong; Robert F Anda; Vincent J Felitti; Shanta R Dube; David F Williamson; Theodore J Thompson; Clifton M Loo; Wayne H Giles Journal: Child Abuse Negl Date: 2004-07
Authors: Jon D Elhai; Megan E Miller; Julian D Ford; Tracey L Biehn; Patrick A Palmieri; B Christopher Frueh Journal: J Anxiety Disord Date: 2011-09-03
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Elie G Karam; Matthew J Friedman; Eric D Hill; Ronald C Kessler; Katie A McLaughlin; Maria Petukhova; Laura Sampson; Victoria Shahly; Matthias C Angermeyer; Evelyn J Bromet; Giovanni de Girolamo; Ron de Graaf; Koen Demyttenaere; Finola Ferry; Silvia E Florescu; Josep Maria Haro; Yanling He; Aimee N Karam; Norito Kawakami; Viviane Kovess-Masfety; María Elena Medina-Mora; Mark A Oakley Browne; José A Posada-Villa; Arieh Y Shalev; Dan J Stein; Maria Carmen Viana; Zahari Zarkov; Karestan C Koenen Journal: Depress Anxiety Date: 2013-08-27 Impact factor: 6.505
Authors: Chiung M Chen; Young-Hee Yoon; Thomas C Harford; Bridget F Grant Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2017-04-11 Impact factor: 4.328
Authors: Sophie E Holmes; Matthew J Girgenti; Margaret T Davis; Robert H Pietrzak; Nicole DellaGioia; Nabeel Nabulsi; David Matuskey; Steven Southwick; Ronald S Duman; Richard E Carson; John H Krystal; Irina Esterlis Journal: Proc Natl Acad Sci U S A Date: 2017-07-17 Impact factor: 11.205
Authors: Krishnan Radhakrishnan; Mihaela Aslan; Kelly M Harrington; Robert H Pietrzak; Grant Huang; Sumitra Muralidhar; Kelly Cho; Rachel Quaden; David Gagnon; Saiju Pyarajan; Ning Sun; Hongyu Zhao; Michael Gaziano; John Concato; Murray B Stein; Joel Gelernter Journal: Int J Methods Psychiatr Res Date: 2019-02-14 Impact factor: 4.035
Authors: Anna Persson; Sudie E Back; Therese K Killeen; Kathleen T Brady; Melanie L Schwandt; Markus Heilig; Åsa Magnusson Journal: J Addict Med Date: 2017 Mar/Apr Impact factor: 3.702
Authors: Ryan E Tyler; Benjamin Z S Weinberg; Dennis F Lovelock; Laura C Ornelas; Joyce Besheer Journal: Genes Brain Behav Date: 2020-08-25 Impact factor: 3.449
Authors: Christina M Sheerin; Mackenzie J Lind; Emily A Brown; Charles O Gardner; Kenneth S Kendler; Ananda B Amstadter Journal: Depress Anxiety Date: 2017-11-24 Impact factor: 6.505